Increased serum S100B protein in the first-episode medication-free patients with schizophrenia

HAN Xiaole,TAN Yunlong,YANG Fude,WANG Zhiren,LI Yingli,CHEN Song,WANG Yuechan,ZOU Yizhuang,ZHOU Dongfeng
2009-01-01
Abstract:Objective To investigate the correlation of the serum S100B protein levels with psychopathological symptoms in first-episode medication-free patients with schizophrenia. Methods The serum S100B protein levels in 64 first-episode medication-free schizophrenic patients (schizophrenic group) and 66 healthy volunteers (control group) were examined by enzyme-linked immuno-sorbent assay (ELSIA). Psychopathological symptoms were assessed by using the Positive and Negative Symptom Scale(PANSS),the relationship of the serum S100B levels and the PANSS scores were analyzed in schizophrenic group. Results ①The serum S100B levels in schizophrenic group(0.27±0.13)μg/L were significantly higher than those of the control group(0.11±0.04)μg/L(P<0.001); ②Significant differences were found among four sub-groups in schizophrenics(F=4.63,P=0.006),the serum S100B levels of the patients with residential sub-type were significantly higher than those of the patients with paranoid(P=0.001)and disorganized(P=0.012); Moreover,the serum S100B levels four sub-types group were significantly higher than those of the control group(P<0.001) ③The serum S100B levels markedly correlated with age,ill duration and negative and total score of the PANSS(all P<0.005)in schizophrenic group. Conclusions The serum S100B protein levels in first-episode medication-free patients with schizophrenia are increased,and correlated with psychopathological symptoms which indicate that serum S100B protein level might reflect the severity of schizophrenia in some degree.
What problem does this paper attempt to address?